⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5276520 | 0.80 | SMN1; SMN2 (0.32) | — | |
| SCHEMBL31624255 | 0.75 | — | — | |
| SCHEMBL22474030 | 0.75 | KCNH2 (0.36) | — | |
| SCHEMBL23758331 | 0.70 | SMN1; SMN2 (0.49) | — | |
| SCHEMBL5323759 | 0.68 | — | — | |
| SCHEMBL13180314 | 0.66 | TDP1 (0.33) | — | |
| SCHEMBL24665881 | 0.64 | POLB (0.35) | — | |
| SCHEMBL11967281 | 0.63 | MAP3K5 (0.31) | — | |
| SCHEMBL11967288 | 0.63 | ADRA1A (0.32) | — | |
| SCHEMBL24185368 | 0.62 | P2RX7 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020046975-A1 | METHODS OF TREATING NEURODEGENERATIVE DISEASES | Seal Rock Therapeutics, Inc. (US) | 2020-03-05 | — | — | WO | disclosed |